Advertisement

FDA OKs Drug Application by Gensia Sicor

Dow Jones

Gensia Sicor Inc.'s pharmaceuticals unit received approval from the Food and Drug Administration for its abbreviated new drug application for daunorubicin hydrochloride for injection.

Irvine-based Gensia Sicor said daunorubicin hydrochloride is a drug for remission induction in acute myelogenous leukemia in adults and acute lymphocytic leukemia in children and adults.


Advertisement
Advertisement